Sage Therapeutics
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
215 1st St, Cambridge, Massachusetts, 02...Phone Number
(617) 299-8380Website
www.sagerx.comRevenue
$41.2 MillionIndustry
About Sage Therapeutics
Supernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing and commercializing products for central nervous system (CNS) diseases. The company focuses on research and development to create novel therapeutic products that provide significant health benefits to patients. Their portfolio includes a range of innovative treatments aimed at improving the lives of those affected by CNS disorders. Supernus serves patients and healthcare providers, emphasizing the importance of their contributions to the biopharmaceutical landscape.Explore more
Sage Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Sage Therapeutics
Compare insights from companies similar to Sage Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sage Therapeutics Tech Stack
A closer look at the technologies used by Sage Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sage Therapeutics
Sign Up For FreeTo access detailed company insights
Supernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing and commercializing products for central nervous system (CNS) diseases. The company focuses on research and development to create novel therapeutic products that provide significant health benefits to patients. Their portfolio inclu... Read More
